Strategic Projects
Initiatives
Useful Links
News
02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
01/2026
Interview with Nataša Jenčić, general manager at Biogen...
Innovative Pharmaceutical Initiative – iF!
Delaying Alzheimer’s disease
Scientists are investigating more than 100 new drugs that could enable patients to live more independently.
More pain‑free days for people with migraines
New therapies in development will reduce migraine attacks and enable patients to enjoy a better quality of life.
Preventing infections
Microbiome therapies can prevent the recurrence of infections caused by Clostridium difficile. The number of cases could be reduced by 90%.
Preventing liver transplantation
Therapies for non-alcoholic steatohepatitis can reduce the buildup of fat in the liver. As a result, as many as 12,000 Europeans per year could avoid the need for a liver transplant.
Fight against diabetes
With cell therapies, blood sugar levels could be controlled in nearly 4 million Europeans living with type 1 diabetes.
Creating a world without hemophilia B
Gene therapy can improve the quality of life of people living with disease by reducing the need for intensive, lifelong treatment.
Fighting blood cancer
CAR‑T cell therapy could cure cancers that are currently incurable.
Better prospects for patients with lung cancer
Combination therapy could prevent the deaths of 30,000 people with non-small cell lung cancer.
Fighting bacterial infections
With more than 1,000 medicines in development, antibacterial antibodies could save 25,000 lives every year in Europe.
Bacterial infections
We won't rest until antibacterial monoclonal antibodies succeed in slowing antibiotic resistance and fighting bacterial infections.
Type 1 diabetes
We won't rest until cell therapy replaces regular insulin therapy for patients with diabetes.
Alzheimer’s disease
Alzheimer’s disease is one of the greatest public health crises in Europe, but we will not give up until new treatments stop the progression of the disease.
Lung cancer
Using combination treatment increases their effectiveness, helping people with lung cancer live longer; there will be no respite until non‑small cell lung cancer can be brought under control or even cured.
Haemophilia
Gene therapy offers the potential to transform the lives of patients with haemophilia B, and we will not relent until similar rare diseases can be eased or cured.
Blood cancer
We won't rest until CAR‑T cell therapy helps patients avoid lifelong treatment.
> Clinical practice guidelines and monitoring treatment outcomes
Clinical practice guidelines and monitoring treatment outcomes
Updating the collection of clinical practice guidelines is recognized as an important tool for improving health services, patient pathway through the healthcare system, and improving treatment outcomes.
The role of the innovative pharmaceutical industry is to seek the best possible solutions for unmet medical needs in order to increase the availability of new, revolutionary therapies for all patients and improve treatment outcomes. iF! actively and in good faith collaborates with all stakeholders in healthcare to achieve this goal.
Updating the collection of treatment guidelines has been recognized as an important tool for improving healthcare services.
When it comes to the most difficult and widespread diseases, the outcomes of treatments are mostly dependent on the availability of innovative therapies and the ability of our physicians to prescribe for each patient the therapy that will in his/her case bring the most benefits, or the best outcomes.
The timely availability of the latest therapies is in the best interest of patients, healthcare professionals, and ultimately the healthcare system. By directing resources toward the best treatment outcomes, healthcare costs could be optimized in the most effective way, freeing up funds for innovative, individualized therapies that have been proven to deliver the best results.
You can learn more here about the importance of monitoring treatment outcomes.